Literature DB >> 21074729

Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Andrew D Rhim1, Ben Z Stanger.   

Abstract

Embryonic development marks a period of peak tissue growth and morphogenesis in the mammalian lifecycle. Many of the pathways that underlie cell proliferation and movement are relatively quiescent in adult animals but become reactivated during carcinogenesis. This phenomenon has been particularly well documented in pancreatic cancer, where detailed genetic studies and a robust mouse model have permitted investigators to test the role of various developmental signals in cancer progression. In this chapter, we review current knowledge regarding the signaling pathways that act during pancreatic development and the evidence that the reactivation of developmentally important signals is critical for the pathogenesis of this treatment-refractory malignancy.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21074729      PMCID: PMC3117430          DOI: 10.1016/B978-0-12-385233-5.00002-7

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  218 in total

Review 1.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

2.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Beta-catenin is essential for pancreatic acinar but not islet development.

Authors:  L Charles Murtaugh; Anica C Law; Yuval Dor; Douglas A Melton
Journal:  Development       Date:  2005-09-28       Impact factor: 6.868

4.  BMP4-BMPR1A signaling in beta cells is required for and augments glucose-stimulated insulin secretion.

Authors:  Joan Goulley; Ulf Dahl; Nathalie Baeza; Yuji Mishina; Helena Edlund
Journal:  Cell Metab       Date:  2007-03       Impact factor: 27.287

5.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

6.  Epithelial-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia.

Authors:  Maamoun M Al-Aynati; Nikolina Radulovich; Robert H Riddell; Ming-Sound Tsao
Journal:  Clin Cancer Res       Date:  2004-02-15       Impact factor: 12.531

7.  Notch signaling is required for exocrine regeneration after acute pancreatitis.

Authors:  Jens T Siveke; Clara Lubeseder-Martellato; Marcel Lee; Pawel K Mazur; Hassan Nakhai; Freddy Radtke; Roland M Schmid
Journal:  Gastroenterology       Date:  2007-11-04       Impact factor: 22.682

8.  Detection of genetic alterations in pancreatic cancers by comparative genomic hybridization coupled with tissue microdissection and degenerate oligonucleotide primed polymerase chain reaction.

Authors:  Tomohiko Harada; Kiwamu Okita; Kei Shiraishi; Noriyoshi Kusano; Tomoko Furuya; Atsunori Oga; Shigeto Kawauchi; Satoshi Kondoh; Kohsuke Sasaki
Journal:  Oncology       Date:  2002       Impact factor: 2.935

9.  A bipotential precursor population for pancreas and liver within the embryonic endoderm.

Authors:  G Deutsch; J Jung; M Zheng; J Lóra; K S Zaret
Journal:  Development       Date:  2001-03       Impact factor: 6.868

10.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

View more
  17 in total

1.  Decreased RGS6 expression is associated with poor prognosis in pancreatic cancer patients.

Authors:  Nan Jiang; Ruihua Xue; Fangfang Bu; Xin Tong; Jiankun Qiang; Rong Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.

Authors:  Sanjeev K Srivastava; Arun Bhardwaj; Seema Singh; Sumit Arora; Bin Wang; William E Grizzle; Ajay P Singh
Journal:  Carcinogenesis       Date:  2011-10-07       Impact factor: 4.944

Review 3.  The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.

Authors:  Anteneh A Tesfaye; Mandana Kamgar; Asfar Azmi; Philip A Philip
Journal:  Expert Rev Anticancer Ther       Date:  2017-12-19       Impact factor: 4.512

4.  Pancreatic cancer: translational research aspects and clinical implications.

Authors:  Daniel Ansari; Bi-Cheng Chen; Lei Dong; Meng-Tao Zhou; Roland Andersson
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

Review 5.  A starring role for stellate cells in the pancreatic cancer microenvironment.

Authors:  Minoti V Apte; Jeremy S Wilson; Aurelia Lugea; Stephen J Pandol
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

Review 6.  Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.

Authors:  Bryan D White; Andy J Chien; David W Dawson
Journal:  Gastroenterology       Date:  2011-12-08       Impact factor: 22.682

Review 7.  Pancreatic cancer and its stroma: a conspiracy theory.

Authors:  Zhihong Xu; Srinivasa P Pothula; Jeremy S Wilson; Minoti V Apte
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.

Authors:  Seema Chugh; Srikanth Barkeer; Satyanarayana Rachagani; Rama Krishna Nimmakayala; Naveenkumar Perumal; Ramesh Pothuraju; Pranita Atri; Sidharth Mahapatra; Ishwor Thapa; Geoffrey A Talmon; Lynette M Smith; Xinheng Yu; Sriram Neelamegham; Jianxin Fu; Lijun Xia; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Gastroenterology       Date:  2018-08-04       Impact factor: 22.682

9.  Prostaglandin E2 regulates liver versus pancreas cell-fate decisions and endodermal outgrowth.

Authors:  Sahar Nissim; Richard I Sherwood; Julia Wucherpfennig; Diane Saunders; James M Harris; Virginie Esain; Kelli J Carroll; Gregory M Frechette; Andrew J Kim; Katie L Hwang; Claire C Cutting; Susanna Elledge; Trista E North; Wolfram Goessling
Journal:  Dev Cell       Date:  2014-02-13       Impact factor: 12.270

10.  Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.

Authors:  Satyanarayana Rachagani; María P Torres; Sushil Kumar; Dhanya Haridas; Michael Baine; Muzafar A Macha; Sukhwinder Kaur; Moorthy P Ponnusamy; Parama Dey; Parthasarathy Seshacharyulu; Sonny L Johansson; Maneesh Jain; Kay-Uwe Wagner; Surinder K Batra
Journal:  J Hematol Oncol       Date:  2012-10-26       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.